Roche Wins EU Approval Recommendation for Susvimo to Treat Wet AMD
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Roche’s Susvimo, containing ranibizumab, for treating wet age-related macular degeneration. This regulatory step ... Read More